Innova Captab Limited (NSE:INNOVACAP)

Market Cap	51.96B
Revenue (ttm)	12.44B
Net Income (ttm)	1.28B
Shares Out	57.22M
EPS (ttm)	22.41
PE Ratio	40.51
Forward PE	29.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,103
Average Volume	52,471
Open	907.95
Previous Close	907.95
Day's Range	895.00 - 910.95
52-Week Range	501.00 - 1,260.00
Beta	n/a
RSI	58.74
Earnings Date	Aug 5, 2025

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antieme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In 2024, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.